Christopher P. Miller

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

Cozen O'Connor provides legal services. It offers services in areas of business law, including mergers and acquisitions, private equity, venture capital, IPOs, corporate governance and compliance, insurance corporate and regulatory matters, securities, tax, real estate, bankruptcy, intellectual property, health law, public finance, employee benefits, trust and estates, and energy, environmental and public utilities. The company was founded by Stephen A. Cozen and Patrick J. O´Connor in 1970 and is headquartered in Philadelphia, PA.